Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.44 Analyst target: $13.25 Upside: 143.57%
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.